Letermovir(LuciLeter)

Release date: 2026-10-21 14:07:56     Recommended: 2

Indicated for the prevention of cytomegalovirus infection and disease, primarily in adult and pediatric patients at high risk following hematopoietic stem cell transplantation or kidney transplantatio